Dow Down 0.09% Nasdaq Up 0.28%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.35 Down 0.09(5.94%) 10:37AM EDT - Nasdaq Real Time Price
Prev Close:1.43
Open:1.45
Bid:1.37 x 900
Ask:1.38 x 3700
1y Target Est:4.05
Beta:0.64
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.34 - 1.45
52wk Range:1.11 - 3.00
Volume:267,456
Avg Vol (3m):834,365
Market Cap:201.97M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 5.94%201.97M
LLYUp 0.13%68.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):77.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback